Delivery Order SPE2DB20D3103-SPE2DB25FQ0J1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,183.76 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a $36,954.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 22, 2025, is performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $92,395.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's established pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $10,426.99 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $42,594.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-count units. The delivery order, which is expected to be completed by July 29, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6,394.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price terms with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $80,409.74 to supply Biktarvy 50-200-25 mg tablets (30-count bottles) under a firm fixed-price contract with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $6,378.11 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded pharmaceutical procurement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $57,306.06 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0J1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,590.56 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company's place of performance is listed at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support to military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through this arrangement, AmerisourceBergen Drug Corp serves critical customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/27/25 |